7A2-14374-21685
2 vaccinations
1 coded response
24 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 981 / WA
- Registered
- 2022-09-08
- Relationship
- Child or adolescent in my care
- Guardian
- 65E-23917-61964
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-09-07
Dose 1 — Moderna
-
2022-09-08
Registered in v-safe
-
2022-09-08
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · Fever · Irritability/cryingUnder 3 check-in
- 2022-09-09
- 2022-09-10
- 2022-09-11
- 2022-09-12
- 2022-09-13
- 2022-09-14
- 2022-09-21
- 2022-09-28
-
2022-10-14
Dose 2 — Moderna
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-10-18
- 2022-10-19
- 2022-10-20
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2022-11-18
-
2022-11-26
Survey response — day 42, dose 2, under 3MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: GoodFree text: Mild cold with runny nose and coughMedDRA releases: 2024-11 · check-in free text available
- 2023-01-13
- 2023-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-09-07 | Moderna | No |
| 2 | 2022-10-14 | Moderna | No |
Free text
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Mild cold with runny nose and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release